|
MBD2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.16039999997763E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.17599999960305E-07 |
| Normal-vs-Stage2 |
4.010000E-02 |
| Normal-vs-Stage3 |
4.421600E-03 |
| Normal-vs-Stage4 |
7.398300E-03 |
| Stage1-vs-Stage2 |
5.460600E-01 |
| Stage1-vs-Stage3 |
4.483600E-02 |
| Stage1-vs-Stage4 |
5.678000E-02 |
| Stage2-vs-Stage3 |
6.305600E-01 |
| Stage2-vs-Stage4 |
6.502800E-01 |
| Stage3-vs-Stage4 |
9.773200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.60999999963141E-07 |
| Normal-vs-AfricanAmerican |
6.025600E-02 |
| Normal-vs-Asian |
3.775000E-01 |
| Caucasian-vs-AfricanAmerican |
2.835600E-01 |
| Caucasian-vs-Asian |
9.227200E-01 |
| AfricanAmerican-vs-Asian |
7.665800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.73980000000018E-05 |
| Normal-vs-Female |
1.72206999999869E-05 |
| Male-vs-Female |
6.402400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.376400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.22810000002804E-06 |
| Normal-vs-Age(61-80Yrs) |
1.186990E-04 |
| Normal-vs-Age(81-100Yrs) |
9.773700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.482000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.139200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.288800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.364840E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.816800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.875600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.13659999999116E-05 |
| Normal-vs-Grade 2 |
1.98820004904121E-09 |
| Normal-vs-Grade 3 |
1.235850E-03 |
| Normal-vs-Grade 4 |
2.346200E-01 |
| Grade 1-vs-Grade 2 |
3.005200E-01 |
| Grade 1-vs-Grade 3 |
2.487800E-02 |
| Grade 1-vs-Grade 4 |
6.979900E-03 |
| Grade 2-vs-Grade 3 |
4.164100E-04 |
| Grade 2-vs-Grade 4 |
1.020230E-04 |
| Grade 3-vs-Grade 4 |
1.506370E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.54791801177635E-14 |
| Normal-vs-ccB subtype |
3.621000E-01 |
| ccA subtype-vs-ccB subtype |
1.84063875252605E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.841500E-04 |
| Normal-vs-N1 |
7.634200E-02 |
| N0-vs-N1 |
9.999000E-01 |
|
|
